Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 541

1.

Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.

Sáfadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, Racz ML.

Pediatr Infect Dis J. 2010 Nov;29(11):1019-22. doi: 10.1097/INF.0b013e3181e7886a.

PMID:
20543761
2.

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

Nakagomi T, Cuevas LE, Gurgel RG, Elrokhsi SH, Belkhir YA, Abugalia M, Dove W, Montenegro FM, Correia JB, Nakagomi O, Cunliffe NA, Hart CA.

Arch Virol. 2008;153(3):591-3. doi: 10.1007/s00705-007-0028-z. Epub 2008 Jan 4.

PMID:
18175037
3.

Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.

Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, Curns AT, Griffin M, Weinberg GA, Hall CB, Fairbrother G, Alexander J, Parashar UD.

Pediatrics. 2008 Dec;122(6):1235-43. doi: 10.1542/peds.2007-3378.

PMID:
19047240
4.

Rotavirus gastroenteritis in Finnish children in 2006-2008, at the introduction of rotavirus vaccination.

Räsänen S, Lappalainen S, Halkosalo A, Salminen M, Vesikari T.

Scand J Infect Dis. 2011 Jan;43(1):58-63. doi: 10.3109/00365548.2010.508462. Epub 2010 Aug 31.

PMID:
20807022
5.

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.

Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, Guerra SF, Oliveira AS, da Silva VB, Sanchez N, Meyer N, Shafi F, Ortega-Barria E, Soriano-Gabarró M, Colindres RE.

Pediatr Infect Dis J. 2011 May;30(5):396-401. doi: 10.1097/INF.0b013e3182055cc2.

PMID:
21150692
6.

Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009.

Carvalho-Costa FA, Volotão Ede M, de Assis RM, Fialho AM, de Andrade Jda S, Rocha LN, Tort LF, da Silva MF, Gómez MM, de Souza PM, Leite JP.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S35-41. doi: 10.1097/INF.0b013e3181fefd5f.

PMID:
21048523
7.

Reduction in Rotavirus Disease and Sustained Predominance of G2P[4] Rotavirus Strain following Introduction of Rotavirus Vaccine in Recife, Brazil.

Montenegro FM, Falbo AR, Germano EM, Correia NB, Souza Eda S, Nakagomi O, Nakagomi T, Cuevas LE, Cunliffe NA, Correia JB.

J Trop Pediatr. 2015 Jun;61(3):206-9. doi: 10.1093/tropej/fmv006. Epub 2015 Feb 26.

PMID:
25724210
8.

United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.

Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, Cortese MM, Parashar UD, Glass RI, Bowen MD; National Rotavirus Strain Surveillance System.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S42-7. doi: 10.1097/INF.0b013e3181fefd78.

PMID:
21183839
9.

Update on Rotarix: an oral human rotavirus vaccine.

O'Ryan M, Linhares AC.

Expert Rev Vaccines. 2009 Dec;8(12):1627-41. doi: 10.1586/erv.09.136. Review.

PMID:
19943758
10.

Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.

Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H.

Pediatr Infect Dis J. 2010 Apr;29(4):319-23. doi: 10.1097/INF.0b013e3181c18434.

PMID:
19935446
11.

Prevention of rotavirus disease: guidelines for use of rotavirus vaccine.

American Academy of Pediatrics Committee on Infectious Diseases.

Pediatrics. 2007 Jan;119(1):171-82.

PMID:
17200286
13.

Sustained protection from pentavalent rotavirus vaccination during the second year of life at a large, urban United States pediatric hospital.

Boom JA, Tate JE, Sahni LC, Rench MA, Quaye O, Mijatovic-Rustempasic S, Patel MM, Baker CJ, Parashar UD.

Pediatr Infect Dis J. 2010 Dec;29(12):1133-5. doi: 10.1097/INF.0b013e3181ed18ab.

PMID:
20634776
14.

Rotavirus vaccines in Belgium: policy and impact.

Braeckman T, Van Herck K, Raes M, Vergison A, Sabbe M, Van Damme P.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S21-4. doi: 10.1097/INF.0b013e3181fefc51.

PMID:
21183836
15.

Rotavirus strain surveillance for three years following the introduction of rotavirus vaccine into Belém, Brazil.

Guerra SF, Linhares AC, Mascarenhas JD, Oliveira A, Justino MC, Soares LS, Müller EC, Brasil P, Tuboi S, Ortega-Barria E, Colindres R.

J Med Virol. 2015 Aug;87(8):1303-10. doi: 10.1002/jmv.24183. Epub 2015 Apr 16.

PMID:
25879653
16.

Impact and effectiveness of RotaTeq® vaccine based on 3 years of surveillance following introduction of a rotavirus immunization program in Finland.

Vesikari T, Uhari M, Renko M, Hemming M, Salminen M, Torcel-Pagnon L, Bricout H, Simondon F.

Pediatr Infect Dis J. 2013 Dec;32(12):1365-73. doi: 10.1097/INF.0000000000000086.

PMID:
24051998
17.

Effect of human rotavirus vaccine on severe diarrhea in African infants.

Madhi SA, Cunliffe NA, Steele D, Witte D, Kirsten M, Louw C, Ngwira B, Victor JC, Gillard PH, Cheuvart BB, Han HH, Neuzil KM.

N Engl J Med. 2010 Jan 28;362(4):289-98. doi: 10.1056/NEJMoa0904797.

18.

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.

Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S25-9. doi: 10.1097/INF.0b013e3181fefdee. Erratum in: Pediatr Infect Dis J. 2011 Oct; 30(10):916.

PMID:
21183837
19.

Rotavirus incidence and genotype distribution before and after national rotavirus vaccine introduction in Belgium.

Zeller M, Rahman M, Heylen E, De Coster S, De Vos S, Arijs I, Novo L, Verstappen N, Van Ranst M, Matthijnssens J.

Vaccine. 2010 Nov 3;28(47):7507-13. doi: 10.1016/j.vaccine.2010.09.004. Epub 2010 Sep 17.

PMID:
20851085
20.

Distribution of rotavirus genotypes after introduction of rotavirus vaccines, Rotarix® and RotaTeq®, into the National Immunization Program of Australia.

Kirkwood CD, Boniface K, Barnes GL, Bishop RF.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S48-53. doi: 10.1097/INF.0b013e3181fefd90.

PMID:
21183840

Supplemental Content

Support Center